Dl-tryptophan methyl ester hydrochloride, 97.0%, 25g

3-(5-Methyl-1,3,4-thiadiazol-2-yl)-6-[4-[2-(trifluoromethyl)phenoxy]-1-piperidinyl]pyridazine, 95%, 10mg

GC capillary column ROTI®Cap-1, 30 m, 0.53 mm, 0.50 µm, 1 Piece(s)

Imidodicarbonic acid, 2-(3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-, 1,3-bis(1,1-dimethylethyl) ester, 97%, 100mg

6-Bromo-N-methyl-2-naphthamide, 95.0%, 5g

2-(Trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine, 95.0%, 250mg

2,3-Dimethoxy-6-methylpyridine, 97%, 100mg

TOSEDOSTAT, 95%, 10mg

4-Bromo-1H-indole-2-carbonitrile, 95.0%, 250mg

1-(4-Bromophenyl)-1-(4-methoxyphenyl)methylamine, 97.0%, 1g

N,N-Dimethylpyrimidin-4-amine, 95.0%, 100mg

(E)-4-Fluorophenethyl 3-(3-hydroxy-4-(methylsulfonyl)phenyl)acrylate, 25mg

4-Cyano-4-(dodecylsulfanylthiocarbonyl)sulfanylpentanoic acid, 95%, 25g